We caught up with Dr Peter Clemmensen (Department of General and Interventional Cardiology, University Heart Center, Hamburg, Germany) at C3 2019 for his thoughts on the management of right bundle-branch block (RBBB), along with the potential elevated cardiovascular risk in patients with acute coronary syndrome, the need for coronary angiography and his practical advice for physicians managing RBBB.
Speaker’s Disclosures: Peter Clemmensen has a research contract with Philips Healthcare.
1. Can you explain why right bundle-branch block (RBBB) presents such elevated potential cardiovascular risk in patients with acute coronary syndrome? (0:04)
2. Recent findings suggest that RBBB is an indication for coronary angiography – can you explain in which patient populations this is most appropriate? (0:37)
3. What practical advice would you share with physicians managing RBBB in their patients, and how should they consider selection of acute angiography as part of their treatment strategy? (2:16)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
Share this Video
Related Videos In Cardiovascular Disease
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the substudy of the FAME 3 trial and the implications for clinical practice. […]
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part […]
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!